Volumetric Analysis in the Assessment of Therapy Response by CT
NCT00582751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2010-11-02
Summary
To compare the volumetric response achieved using semi-automated computer techniques with the uni-dimensional (RECIST) and bi-dimensional (WHO) criteria as part of clinical trials running at MSKCC, testing new agents for different types of solid tumors.
Conditions
- Multiple Diseases
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Robert Lefkowitz, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- United States
Study Locations
More Related Trials
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors
NCT02526511 ·Status: UNKNOWN ·Phase: NA
-
Quantitative MRI in Assessing Disease in Patients With Brain Tumors
NCT02269111 ·Status: TERMINATED ·Phase: NA
-
Demonstration of the "SPECT/CT System With CZT Detectors" Imaging Performance in a Clinical Setting
NCT03229772 ·Status: COMPLETED ·Phase: NA
-
Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer
NCT06735105 ·Status: RECRUITING ·Phase: NA
-
Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy
NCT03403361 ·Status: TERMINATED ·Phase: NA
-
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
NCT02156739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality
NCT03980535 ·Status: COMPLETED ·Phase: NA
-
DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis
NCT03685539 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of the Diagnostic Accuracy of 3D Volume Acquisition MRI With CT in Staging Colonic Cancer
NCT01187641 ·Status: COMPLETED
-
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
NCT06448208 ·Status: ACTIVE_NOT_RECRUITING
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer
NCT06455761 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
68Ga-labeled NY105 PET Imaging in Patients
NCT05691881 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
7T MRI Scan for the Early Detection of Melanoma Brain Metastases
NCT04941430 ·Status: TERMINATED ·Phase: NA
-
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
NCT02277561 ·Status: WITHDRAWN ·Phase: NA
-
DCE-MRI for Assessment of Response to TACE of HCC
NCT02878109 ·Status: COMPLETED
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT03076333 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
NCT06240741 ·Status: COMPLETED ·Phase: PHASE3
-
Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy
NCT01082224 ·Status: UNKNOWN ·Phase: NA